GlassScriptPhysician profile
Paul S Dagher
NPI 1871588434
$9,464.37
in general payments reported to CMS, 2019-2025
21 companies · $2,099 in 2025
The $2,099 reported for 2025 was more than what 82% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2020: $131 · 2023: $101 · 2024: $7,014 · 2025: $2,099.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,500 · Food and Beverage: $2,104 · Travel and Lodging: $1,600 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,500.00 |
| Food and Beverage | $2,104.48 |
| Travel and Lodging | $1,600.04 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,532.89 | 2024-2025 | |
| Stryker Corporation | $121.30 | 2024 | 1788 |
| Musculoskeletal Transplant Foundation INC. | $117.00 | 2019-2020 | |
| Boston Scientific Corporation | $115.53 | 2023-2025 | Spyglass Discover |
| Hologic Sales and Service, LLC | $97.78 | 2024-2025 | Biozorb, Trunode, Magseed |
| Smith+Nephew, INC. | $81.67 | 2020-2025 | Stravix Pl, Regranex, Collagenase Santyl |
| Davol INC. | $54.92 | 2025 | Phasix Mesh |
| Merck Sharp & Dohme LLC | $45.82 | 2023-2025 | Keytruda, Keytruda Qlex |
| Tactile Systems Technology INC | $31.15 | 2019-2023 | Entre Plus, Flexitouch Plus |
| Medtronic, INC. | $31.10 | 2024 | Eea, Signia |
| Braintree Laboratories, INC. | $29.31 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $27.75 | 2023 | Gattex |
| Portola Pharmaceuticals, LLC | $26.35 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $22.87 | 2024 | Tagrisso |
| Reapplix INC. | $21.00 | 2025 | 3c Patch Kit - Box |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $19.28 | 2024 | Cologuard Collection Kit |
| Covidien LP | $19.08 | 2019 | |
| Kerecis Limited | $18.91 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Bard Peripheral Vascular, INC. | $18.17 | 2024 | Venclose Maven Catheter |
| Acelrx Pharmaceuticals, INC. | $16.63 | 2019 | |
| Paratek Pharmaceuticals, INC. | $15.86 | 2024 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Dagher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.